ilikefinance

Equinix Drops a Cool $160 Million on New Data Center in South Africa – Because Who Doesn’t Love a Good Investment in Tech?

Equinix Expands in South Africa with a $160 Million Investment in a Data Center It’s All About Connectivity With the new investment, Equinix is strategically positioning itself in a crucial connectivity hub for digital networks. The South African market has a vast network of submarine communications cables that stretch across the country’s extensive coastline. This…

Read More

Attention Investors: Don’t Miss Out on the Deadline for the Torrid Holdings Inc. Class Action Lawsuit – A Friendly Reminder from Glancy Prongay Murray LLP!

Welcome to the World of Class Action Lawsuits What’s the deal with Torrid Holdings Inc. (CURV)? So, apparently there’s this company called Torrid Holdings Inc. (CURV) that some investors are not too happy with. According to Glancy Prongay & Murray LLP, there’s a class action lawsuit filed on behalf of investors who purchased or acquired…

Read More

Breaking News: Eurozone Sentix Investor Confidence Soars to 21, Indicating an End to Recessions Before They Begin!

Eurozone Sentix Investor Confidence rose to -21, recession ends before it’s begun December numbers show positive trend Eurozone Sentix Investor Confidence saw a significant rise in December, with the index climbing from -30.9 to -21.0. This is the highest level recorded since June, indicating a promising outlook for the region’s economy. The Current Situation Index…

Read More

MaxCyte Partners with Curamys to Advance Cell and Gene Therapies for Rare Diseases: A Strategic Platform License Agreement

MaxCyte Signs Strategic Platform License with Curamys to Enable Advancements in Cell Fusion Technology ROCKVILLE, Md. and SEOUL, South Korea, Dec. 04, 2022 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics… MaxCyte, Inc., a…

Read More